Shares in Cambridge Nutritional Sciences rose 17% after the company confirmed the resolution of a long-running health and safety case with no material financial impact.
The specialist diagnostics firm announced on Friday that a court had imposed a £35,000 fine on its subsidiary Omega Diagnostics in relation to historic breaches dating back to 2018. The infractions concerned Omega South West, a business sold that same year and no longer part of the group.
The court acknowledged that there had been no deliberate wrongdoing or disregard for the law, citing a strong safety record, full cooperation, and early guilty pleas as mitigating factors. The fine had already been accounted for in the group’s provisions, and no further legal action is expected.
The conclusion of the case removes a lingering uncertainty for the company and clears the way for a clean disclosure in its upcoming annual report, boosting investor sentiment and lifting the stock.
The shares rose 0.43p to 2.98p.